Get the Stockscreener App
1.43
0.70%
0.01
Medicinova Inc stock is traded at $1.43, with a volume of 57,153.
It is up +0.70% in the last 24 hours and up +17.21% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.42
Open:
$1.43
24h Volume:
57,153
Relative Volume:
0.07
Market Cap:
$70.14M
Revenue:
$134.60K
Net Income/Loss:
$-11.81M
P/E Ratio:
-5.9361
EPS:
-0.2409
Net Cash Flow:
$-10.05M
1W Performance:
-7.74%
1M Performance:
+17.21%
6M Performance:
+2.88%
1Y Performance:
-28.50%
1-Day Range:
$1.40
$1.4547
1-Week Range:
$1.40
$1.53
52-Week Range:
$1.13
$2.48
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.43 | 69.65M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
Can MediciNova Inc. stock attract ESG capital inflowsPortfolio Return Summary & Weekly Stock Breakout Alerts - newser.com
Can MediciNova Inc. stock beat market expectations this quarterCPI Data & Weekly Breakout Stock Alerts - newser.com
Will MediciNova Inc. stock continue upward momentumJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - newser.com
Trend analysis for MediciNova Inc. this weekJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Will MediciNova Inc. stock maintain growth story2025 Top Decliners & Daily Profit Focused Screening - newser.com
What Fibonacci levels say about MediciNova Inc. reboundWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
What dividend safety score for MediciNova Inc. stockShort Setup & Real-Time Chart Breakout Alerts - newser.com
Is MediciNova Inc. stock a contrarian buy2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Applying big data sentiment scoring on MediciNova Inc.2025 Key Highlights & Smart Swing Trading Alerts - newser.com
MediciNova appoints former FDA official as clinical advisor By Investing.com - Investing.com Nigeria
MediciNova appoints former FDA official as clinical advisor - Investing.com India
MediciNova, Inc. Appoints Dr. Christopher D. Breder as Clinical and Regulatory Advisor - Quiver Quantitative
MediciNova (NASDAQ: MNOV) names FDA expert Dr. Breder clinical and regulatory advisor - Stock Titan
How currency fluctuations impact MediciNova Inc. stockJuly 2025 Update & Verified Momentum Watchlists - newser.com
Will MediciNova Inc. stock remain a Wall Street favoriteIPO Watch & Reliable Breakout Forecasts - newser.com
What’s next for MediciNova Inc. stock priceTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Applying Elliott Wave Theory to MediciNova Inc.Weekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will MediciNova Inc. stock benefit from infrastructure spendingInsider Selling & Daily Market Momentum Tracking - newser.com
Developing predictive dashboards with MediciNova Inc. dataWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):